SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Irvine S, Munro R, Porter D. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 1999; 58: 5103.
  • 2
    Van de putte LBA, Van Gestel AM, Van Riel PLCM. Early treatment in rheumatoid arthritis: rationale, evidence and implications. Ann Rheum Dis 1998; 57: 5112.
  • 3
    Mikuls TR, O'Dell J. The changing face of rheumatoid arthritis therapy: results of serial surveys. Arthritis Rheum 2000; 43: 4645.
  • 4
    Walker DJ, Pound JD, Griffiths ID, Powell RJ. Rheumatoid factor tests in the diagnosis and prediction of rheumatoid arthritis. Ann Rheum Dis 1986; 45: 68490.
  • 5
    Wolfe F, Cathey MA, Roberts FK. The latex test revisited: rheumatoid factor testing in 8287 rheumatic disease patients. Arthritis Rheum 1991; 34: 95160.
  • 6
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 7
    Bläß S, Engel JM, Burmester GR. Review: the immunologic homunculus in rheumatoid arthritis. Arthritis Rheum 1999; 42: 2499506.
  • 8
    Saraux A, Berthelot JM, Le Henaff C, Chales G, Thorel JB, Hoang S, et al. Classification and diagnostic value of the 1987 ACR criteria for rheumatoid arthritis (RA) in early arthritis (EA). Arthritis Rheum 2000; 43 Suppl 9: S154.
  • 9
    Saraux A, Bendaoud B, Dueymes M, LeGoff P, Youinou P. Functional affinity of IgM rheumatoid factor in rheumatoid arthritis. Ann Rheum Dis 1997; 56: 1269.
  • 10
    Youinou P, Le Goff P, Dumay A, Lelong A, Fauquert P, Jouquan J. The antiperinuclear factor. I. Clinical and serological associations. Clin Exp Rheumatol 1990; 8: 16.
  • 11
    Meyer O, Tauxe F, Fabregas D, Gabay C, Goycochea M, Haim T, Elias A, Kahn MF. Anti-RA 33 antinuclear antibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies. Clin Exp Rheumatol 1993; 11: 4738.
  • 12
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1979; 227: 6805.
  • 13
    Youinou P, Pennec YL, Casurd-Budd R, Dueymes M, Lamour A. Galactose terminating oligosaccharides of IgG in patients with primary Sjögren's syndrome. J Autoimmun 1992; 5: 393400.
  • 14
    Mihailov C, Lamour A, Bendaoud B, Dueymes M, Pennec YL, Mottier D, et al. Isotype-specific assays for circulating complexes are of value in distinguishing various connective tissue diseases. Med Sci Res 1992; 20: 74951.
  • 15
    Rodriguez MA, Bankurst AD, William RC, Troup GM, Stastny P. Studies on the relationship between HLA DR4 and in vitro IgM factor production. Clin Immunol Immunopathol 1983; 27: 96109.
  • 16
    Siegel S. Nonparametric statistics for the behavioural sciences. New York: McGraw Hill; 1956. p. 11627.
  • 17
    Metz LE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 28398.
  • 18
    Mosmer DW, Lemeshow S. Applied regression analysis. New York: John Wiley & Sons; 1989. p. 10610.
  • 19
    Adebajo AO, Cawtson TE, Hazleman BL. Routine quantitation of rheumatoid factors: ELISA or nephelometry? Scand J Rheumatol 1992; 21: 3024.
  • 20
    Svedler W, Wallman J, Froelich CJ, Teodorescu M. Routine measurement of IgM, IgG and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis. J Rheumatol 1997; 24: 103744.
  • 21
    Roberts-Thompson PJ, Langhans T, McEvoy R, Hollingsworth PN, Bonifacio E, Dawkins RL, et al. SEAPAL quality control analysis of rheumatoid factor measurement in 29 diagnostic laboratories. Ann Rheum Dis 1987; 46: 41720.
  • 22
    Silvestris F, Goodwin JS, Williams RC Jr IgM, IgA and IgG rheumatoid factors in patients with rheumatoid arthritis and normal donors. Clin Rheumatol 1985; 4: 3928.
  • 23
    Highton J, Hessian PA, Small B, Palmer DG. An assessment of the diagnostic value of quantitative measurements of IgA rheumatoid factor. J Rheumatol 1985; 12: 8548.
  • 24
    Powell RJ, Leyiand AM, Pound JD, Bossingham DH. An improved assay for IgG rheumatoid factor: its value in the diagnosis of rheumatoid arthritis. J Rheumatol 1985; 12: 42731.
  • 25
    Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC. IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 1987; 46: 6571.
  • 26
    Van Leeuwen MA, Westra J, Limburg PC, De Jong HJ, Marrink J, Van Rijswijk MH. Quantitation of IgM, IgA and IgG rheumatoid factors by ELISA in rheumatoid arthritis and other rheumatic disorders. Scand J Rheumatol 1988; Suppl 75: 2531.
  • 27
    Kleveland G, Egeland T, Lea T. Quantitation rheumatoid factors (RF) of IgM, IgA, and IgG isotypes by a simple and sensitive ELISA: discrimination between false and true IgG-RF. Scand J Rheumatol 1988; 75 Suppl: 1524.
  • 28
    March RE, Kirwan JR, Davies PG, Winrow VR, Holborow EJ. Sensitive ELISA measurement of IgA, IgG and IgM antiglobulins and other diseases and a comparison of their specificity in rheumatoid arthritis and infectious mononucleosis. Scand J Rheumatol 1987; 16: 4459.
  • 29
    Visser H, Gelink LBS, Kaamphraath AH, Breedvald FC, Hazes JMW. Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factors assays in rheumatoid arthritis. Ann Rheum Dis 1996; 55: 15761.
  • 30
    Newkirk MM, Fournier MJ, Shiroky J. Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic RFs which correlate with disease parameters and with the Gal(0) glycoform of IgG. J Clin Immunol 1995; 15: 2507.
  • 31
    Després N, Talbot G, Plouffe B, Boire G, Ménard HA. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest 1995; 95: 18916.
  • 32
    Mimori T, Suganuma K, Tanami Y, Jojima T, Matsumura M, Fujii T, et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependant neutral protease, calpain) in systemic rheumatic diseases. Med Sci 1995; 92: 726771.
  • 33
    Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, et al. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum 1989; 32: 151520.
  • 34
    Hoet RM, Van Venrooij WJ. The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. In: SmolenJ, KaldenJ, editors. Rheumatoid arthritis. Berlin: Springer-Verlag; 1992. p. 299318.
  • 35
    Berthelot JM, Garnier P, Glemarec J, Flipo RM. Diagnostic value for rheumatoid arthritis of antiperinuclear factor at the 1:100 threshold. Rev Rhum Engl Ed 1998; 65: 914.
  • 36
    Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux JJ, Cantagrel A, et al. Immunoblotting detection of autoantibodies to human epidermidis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol 1998; 25: 83846.
  • 37
    Slack SL, Mannik M, Dale BA. Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol 1998; 25: 84751.
  • 38
    Schellekens GA, Visser H, de Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155163.
  • 39
    Després N, Boire G, Lopez-Longo FJ, Ménard HA. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 1994; 21: 102733.
  • 40
    Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, et al. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol 1999; 26: 713.
  • 41
    Bond A, Alavi A, Axford JS, Bourke BE, Bruckner FE, Kerr MA, et al. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J Autoimmun 1997; 10: 7785.
  • 42
    Young A, Sumar N, Bodman K, Goyal S, Sinclair H, Roitt I, et al. Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum 1991; 34: 14259.
  • 43
    Aho K, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Leino A, et al. Serum immunoglobulin and the risk of rheumatoid arthritis. Ann Rheum Dis 1997; 56: 3516.
  • 44
    Kay RA, Wood KJ, Bernstein RM, Holt PJL, Pumphrey RSH. An IgG subclass imbalance in connective tissue disease. Ann Rheum Dis 1988; 47: 53641.
  • 45
    McDougal JS, Hubbard M, McDuffie F, Strobel PL, Smith SJ, Bass N, et al. Comparison of five assays for immune complexes in the rheumatic diseases: an assessment of their validity for rheumatoid arthritis. Arthritis Rheum 1982; 25: 115666.
  • 46
    Lessard J, Nunnery E, Cecerc F, McDuffy S, Pope RM. Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors. J Rheumatol 1983; 10: 4117.
  • 47
    El Gabalawy HS, Goldbach-Mansky R, Smith D, Arayssi T, Bale S, Gulko P, et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999; 42: 1696705.
  • 48
    Saraux A, Valls I, Voisin V, Koreichi A, Baron D, Youinou P, et al. How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis? Rev Rhum Engl Ed 1995; 62: 1620.
  • 49
    Eberhardt KB, Svensson B, Truedsson L, WoUheim FA. The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis: no relationship with erosions or disease activity. J Rheumatol 1988; 15: 10704.
  • 50
    Möttönen T, Hannonen P, Jokinen I, Arvilommi M, Oka M. Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent-onset rheumatoid arthritis. Scand J Rheumatol 1988; 75 Suppl: 2449.
  • 51
    Van Zeben D, Hazes JMW, Zwinderman AH, Cais A, van der Voort EAM, Breedveld FC. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 1992; 51: 102935.
  • 52
    Withrington RH, Seifert MH. Predominant wrist disease in rheumatoid arthritis associated with high concentration of IgA rheumatoid factor. BMJ 1985; 291: 1388.
  • 53
    Robbins DL, Feigal DW Jr, Leek JC. Relationship of serum IgG rheumatoid factor to IgM rheumatoid factor and disease activity in rheumatoid arthritis. J Rheumatol 1986; 13: 25962.
  • 54
    Jonsson T, Valdimarsson H. Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 1993; 52: 1614.
  • 55
    Van Schaardenburg D, Lagaaij AM, Otten HG, Breedveld FC. The relation between class-specific serum rheumatoid factors and age in the general population. Br J Rheumatol 1993; 32: 1049.
  • 56
    Terkeltaub R, Esdaile J, Decary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983; 10: 41824.
  • 57
    Pease CT, Bhakta BB, Devlin J, Emery P. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology 1999; 38: 22834.
  • 58
    Weyand CM, Schmidt D, Wagner U, Goronzy JJ. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum 1998; 41: 81722.